LifeClean International AB (DE:651)
FRANKFURT:651
Want to see DE:651 full AI Analyst Report?
651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€4.95M
Enterprise Value€33.61M
Total Cash (Recent Filing)€2.14M
Total Debt (Recent Filing)€21.37M
Price to Earnings (P/E)―
Beta4.78
Next Earnings
Jul 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Revenue MomentumTTM revenue growth of about 20% signals durable top-line momentum and improved commercial traction after a weak 2025. Sustained demand across months supports scaling opportunities and provides a foundation to pursue margin recovery if unit economics and mix are improved.
Debt Reduction TrendA meaningful reduction in total debt versus prior years eases near-term refinancing pressure and interest burden. If sustained, lower gross indebtedness increases solvency headroom and gives management more flexibility to fund operational improvements without immediate external capital.
Niche Product & Business ModelSpecialized infection-control chemistry and solutions target professional customers and healthcare settings where performance and compliance matter. This niche positioning can create durable differentiation, higher switching costs, and opportunities for recurring service or distribution partnerships over months.
Bears Say
Negative Gross Profit & Deep LossesNegative gross profit and a TTM net margin near -61% reveal a structurally unprofitable cost base or pricing mismatch. Without sustained gross-margin improvement the company cannot translate revenue growth into viable earnings, leaving profitability reliant on operational restructuring.
Persistent Cash BurnConsistent negative operating and free cash flow (~-22.7m TTM) shows the business cannot self-fund operations or growth. Persistent cash burn forces dependence on external financing or dilution, limiting strategic flexibility and increasing execution risk over the coming months.
High Leverage On Thin EquityVery high debt-to-equity and historically thin or negative equity make the balance sheet fragile amid ongoing losses. Elevated leverage magnifies refinancing and covenant risk, reduces resilience to setbacks, and constrains the company's ability to invest in scaling or margin fixes.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €4.95M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Jul 15, 2026 which is in 55 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Apr 29, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as floors, walls, furniture, and general roof surfaces. The company was founded in 2012 and is based in Uddevalla, Sweden.